Scientists hypothesized that TGF-β receptor inhibition may alter Pancreatic ductal adenocarcinoma progression and antitumor immunity in the tumor microenvironment.
[Molecular Carcinogenesis]
Sorry, but the selected Zotpress account can't be found.
